In order to cut spending and help increase profits of its medical testing sector, Abbott announced in August that it would be laying off about 1,000 people, saving the company about $370 million in the course of four years. Thomas stated that the company "maintains a vast global footprint with equal sales in the U.S. and internationally. We market our products in more than 130 countries and have aggressive growth strategies in the most attractive emerging markets, where we expect to double our sales."Abbott is a leading medical company that researches, develops and manufactures pharmaceutical, diagnostic and nutritional medicines, supplements and equipment. Some of the more well-known products of the company include the painkiller Vicodin, Similac infant formula and Ensure meal replacement products. As part of its North American Industrial Database, Industrial Info is currently tracking $174 million of Abbott's projects in the U.S., Canada and Puerto Rico. While one of the projects involves the closure of its Whippany, N.J., manufacturing plant with its associated equipment dismantlement and environmental monitoring, the largest project of Abbott currently tracked by Industrial Info is the $150 million Phase I construction of the Pleasant Prairie Lifescience Campus in Pleasant Prairie, Wis. The facility will occupy a 500-acre site and eventually encompass 3.5 million square feet of research, light production and administrative facilities. Phase I will involve the construction of over 300,000 feet of the project and is scheduled for completion by the end of 2012.
Industrial Info Resources (IIR) is a marketing information service specializing in industrial process, energy and financial related markets with products and services ranging from industry news, analytics, forecasting, plant and project databases, as well as multimedia services. To learn more, visit www.industrialinfo.com.
